Renaissance Technologies (RenTech)'s TERN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 169,034 shares of Terns Pharmaceuticals, Inc. (TERN) worth $8.91 M, representing 0.01% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TERN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 810,700 shares. Largest reduction occurred in Q2 2025, reducing 511,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Terns Pharmaceuticals (TERN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Terns Pharmaceuticals (TERN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -297,813 | Reduce 63.79% | 169,034 | $52.72 |
| Q4 2025 | -209,987 | Reduce 31.02% | 466,847 | $40.40 |
| Q3 2025 | -245,700 | Reduce 26.63% | 676,834 | $7.51 |
| Q2 2025 | -511,300 | Reduce 35.66% | 922,534 | $3.73 |
| Q1 2025 | +810,700 | Add 130.10% | 1.43 M | $2.76 |
| Q4 2024 | +143,634 | Add 29.95% | 623,134 | $5.54 |
| Q3 2024 | +392,000 | Add 448.00% | 479,500 | $8.34 |
| Q2 2024 | +87,500 | New Buy | 87,500 | $6.81 |
| Q4 2023 | -290,100 | Sold Out | 0 | $0.00 |
| Q3 2023 | +236,900 | Add 445.30% | 290,100 | $5.03 |
| Q2 2023 | -52,000 | Reduce 49.43% | 53,200 | $0.01 |
| Q1 2023 | -9,700 | Reduce 8.44% | 105,200 | $0.01 |
| Q4 2022 | -37,300 | Reduce 24.51% | 114,900 | $0.01 |
| Q3 2022 | -32,216 | Reduce 17.47% | 152,200 | $5.89 |
| Q2 2022 | +116,616 | Add 172.00% | 184,416 | $2.48 |
| Q1 2022 | +67,800 | New Buy | 67,800 | $2.96 |
Renaissance Technologies (RenTech)'s Terns Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Terns Pharmaceuticals, Inc. (TERN) in Q1 2022, acquiring 67,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Terns Pharmaceuticals, Inc. (TERN) for 16 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Terns Pharmaceuticals, Inc. (TERN) was in Q1 2025, adding 1,433,834 shares worth $3.96 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 169,034 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $8.91 M.
As of the Q1 2026 filing, Terns Pharmaceuticals, Inc. (TERN) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Terns Pharmaceuticals, Inc. (TERN) was 1,433,834 shares, as reported at the end of Q1 2025.